ProPhase Labs Statistics
Total Valuation
ProPhase Labs has a market cap or net worth of $98.25 million. The enterprise value is $119.80 million.
Market Cap | 98.25M |
Enterprise Value | 119.80M |
Important Dates
The last earnings date was Thursday, May 9, 2024, before market open.
Earnings Date | May 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ProPhase Labs has 19.08 million shares outstanding. The number of shares has decreased by -0.09% in one year.
Shares Outstanding | 19.08M |
Shares Change (YoY) | -0.09% |
Shares Change (QoQ) | -0.06% |
Owned by Insiders (%) | 17.47% |
Owned by Institutions (%) | 9.09% |
Float | 15.73M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 10.09 |
PS Ratio | 3.42 |
Forward PS | 2.82 |
PB Ratio | 2.19 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 4.17 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.52.
Current Ratio | 1.88 |
Quick Ratio | 1.54 |
Debt / Equity | 0.52 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -19.44 |
Financial Efficiency
Return on equity (ROE) is -45.00% and return on invested capital (ROIC) is -45.16%.
Return on Equity (ROE) | -45.00% |
Return on Assets (ROA) | -25.90% |
Return on Capital (ROIC) | -45.16% |
Revenue Per Employee | $254,115 |
Profits Per Employee | -$208,823 |
Employee Count | 113 |
Asset Turnover | 0.32 |
Inventory Turnover | 5.81 |
Taxes
Income Tax | -8.60M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.73% in the last 52 weeks. The beta is -0.17, so ProPhase Labs's price volatility has been lower than the market average.
Beta (1Y) | -0.17 |
52-Week Price Change | -45.73% |
50-Day Moving Average | 5.61 |
200-Day Moving Average | 4.95 |
Relative Strength Index (RSI) | 48.52 |
Average Volume (30 Days) | 60,279 |
Short Selling Information
The latest short interest is 260,065, so 1.36% of the outstanding shares have been sold short.
Short Interest | 260,065 |
Short Previous Month | 265,115 |
Short % of Shares Out | 1.36% |
Short % of Float | 1.65% |
Short Ratio (days to cover) | 2.61 |
Income Statement
In the last 12 months, ProPhase Labs had revenue of $28.72 million and -$23.60 million in losses. Loss per share was -$1.36.
Revenue | 28.72M |
Gross Profit | 5.29M |
Operating Income | -30.80M |
Pretax Income | -32.20M |
Net Income | -23.60M |
EBITDA | -23.50M |
EBIT | -30.62M |
Loss Per Share | -$1.36 |
Balance Sheet
The company has $1.79 million in cash and $23.34 million in debt, giving a net cash position of -$21.54 million or -$1.13 per share.
Cash & Cash Equivalents | 1.79M |
Total Debt | 23.34M |
Net Cash | -21.54M |
Net Cash Per Share | -$1.13 |
Equity / Book Value | 44.87M |
Book Value Per Share | 2.35 |
Working Capital | 21.14M |
Cash Flow
In the last 12 months, operating cash flow was -$16.94 million and capital expenditures -$3.53 million, giving a free cash flow of -$20.47 million.
Operating Cash Flow | -16.94M |
Capital Expenditures | -3.53M |
Free Cash Flow | -20.47M |
FCF Per Share | -$1.14 |
Margins
Gross margin is 18.41%, with operating and profit margins of -107.27% and -82.18%.
Gross Margin | 18.41% |
Operating Margin | -107.27% |
Pretax Margin | -112.12% |
Profit Margin | -82.18% |
EBITDA Margin | -81.85% |
EBIT Margin | -106.63% |
FCF Margin | -71.30% |
Dividends & Yields
ProPhase Labs does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | 0.09% |
Shareholder Yield | 0.09% |
Earnings Yield | -24.02% |
FCF Yield | -20.84% |
Analyst Forecast
The average price target for ProPhase Labs is $11.00, which is 113.59% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $11.00 |
Price Target Difference | 113.59% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 23, 1997. It was a forward split with a ratio of 2:1.
Last Split Date | Jan 23, 1997 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
ProPhase Labs has an Altman Z-Score of 0.61 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.61 |
Piotroski F-Score | 1 |